| Rating | Not yet rated |
Download a referral letter Download surgeons CV| Name | Prof Gordon Wishart | ||||||||||||||||||||
| GMC Number | 2849856 | ||||||||||||||||||||
| NHS Position: | Consultant Breast & Endocrine Surgeon & | ||||||||||||||||||||
| NHS Hospital: | Addenbrookes Hospital | ||||||||||||||||||||
| NHS City: | Cambridge | ||||||||||||||||||||
| Age | 51 | ||||||||||||||||||||
| Sex | Male | ||||||||||||||||||||
| Location |
Practice Management Services 4 Trumpington Road Cambridge Cambridgeshire CB2 8AF | ||||||||||||||||||||
| Telephone: | 01223 364830 | ||||||||||||||||||||
| Email: | cambreastclinic@btconnect.com | ||||||||||||||||||||
| Website: | None | ||||||||||||||||||||
| Summary: | I am a Cambridge-based Consultant Breast & Endocrine Surgeon and Professor of Cancer Surgery at Anglia Ruskin University. My main clinical interests relate to the delivery of high quality multidisciplinary patient care based on guidelines and evidence-based protocols. I now act as an expert witness in clinical negligence cases especially delay in diagnosis of breast cancer. As an endocrine surgeon I perform parathyroid and thyroid surgery and have established a tertiary referral base for the surrounding area. I have pioneered day-case and focused (minimally invasive) parathyroidectomy in the UK and have published widely on this subject. My main research interests are prediction of outcome and treatment benefit and variation in breast cancer survival. I recently led a team of scientists to produce a new online model (Predict) that estimates survival and treatment benefit following surgery for invasive breast cancer (www.predict.nhs.uk). | ||||||||||||||||||||
| Primary Speciality: | Breast | ||||||||||||||||||||
| Primary Procedures (and frequency performed per year): |
| ||||||||||||||||||||
| Preferred Hospital: | Spire Cambridge Lea Hospital Nuffield Hospital Cambridge | ||||||||||||||||||||
| Secondary Speciality: | Endocrine | ||||||||||||||||||||
| Secondary Procedures (and frequency performed per year): |
| ||||||||||||||||||||
| Preferred Hospital: | Spire Cambridge Lea Hospital Nuffield Hospital Cambridge | ||||||||||||||||||||
| 1st degree/qualification and year | MB ChB (Edinburgh) 1983 | ||||||||||||||||||||
| Partner in multidisciplinary group? | No | ||||||||||||||||||||
| Multifunctional group's website | No details available | ||||||||||||||||||||
| Average consultation cost | £151-£200 | ||||||||||||||||||||
| Date of last appraisal | 02/03/2009 | ||||||||||||||||||||
| Downloadable CV | Click to download | ||||||||||||||||||||
| University affiliations (1) | Professor of Cancer Surgery, Anglia Ruskin University | ||||||||||||||||||||
| Active research interests? | Yes | ||||||||||||||||||||
| Details of active research interests | Breast | ||||||||||||||||||||
| Last 10 publications (1) | The Cambridge Breast IMRT trial: patient and treatment-related risk factors for the development of normal tissue toxicity. Barnett GC, Wilkinson JS, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnett NG, Coles CE. Clin. Oncol. April 2011(Epub ahead of print) | ||||||||||||||||||||
| Last 10 publications (2) | Coles CE, Harris EJ, Donovan EM, Bliss P, Evans PM, Fairfoul J, Mackenzie C, Rawlings C, Syndikus I, Twyman N, Vasconcelos J, Vowler SL, Wilkinson JS, Wilks R, Wishart GC, Yarnold J. Evaluation of implanted gold seeds for breast radiotherapy planning and on treatment verification: a feasibility study on behalf of the IMPORT trialists. Radiother. Oncol. 2011 (Epub ahead of print) | ||||||||||||||||||||
| Last 10 publications (3) | Wishart GC, Bajdik CD, Azzato EM, Dicks E, Greenberg DC, Rashbass J, Caldas C, Pharoah PDP. Population-based validation of prognostic model PREDICT for early breast cancer. Eur J Surg Oncol. 2011; March 1 (Epub ahead of print) | ||||||||||||||||||||
| Last 10 publications (4) | Barnett GC, Wilkinson JC, Moody AM, Wilson CB, Twyman N, Wishart GC, Burnet NG, Coles CE. A randomised controlled trial of forward-planned Intensity Modulated Radiotherapy (IMRT) for early breast cancer: interim results at 2 years. Int J Radiol, Biol, Phys. 2011; Feb 22 (Epub ahead of print). | ||||||||||||||||||||
| Last 10 publications? (5) | Britton P, Warwick J, Wallis MG. Sinnatamby R, O’Keefe S, Taylor K, Barter S, Gaskarth M, Duffy SW, Wishart GC. Measuring the accuracy of breast imaging in symptomatic patients: team and individual performance. Br J Radiol. Jan 11; (Epub ahead of print).` | ||||||||||||||||||||
| Last 10 publications? (6) | Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of England. Ali AMG, Wishart GC, Pharoah PDP. Br J Cancer 2011; 104: 564-570. | ||||||||||||||||||||
| Last 10 publications? (7) | Benson JR & Wishart GC. Is intra-operative nodal assessment essential in a modern breast practice? Eur J Surg Oncol. 2010; 36(12): 1162-4. | ||||||||||||||||||||
| Last 10 publications? (8) | Liau S-S, Cariati M, Noble D, Wilson C, Wishart GC. Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer Ann R Coll Surg Engl 2010; 92: 562-568. | ||||||||||||||||||||
| List last 10 publications? (9) | Wishart GC, Azzato EM, Pharoah PDP, Greenberg DC, Rashbass R, Kearins O, Lawrence G, Caldas C, Ravdin PM. PREDICT: A new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 2010, Jan 6; 12(1): R1 | ||||||||||||||||||||
| Last 10 publications? (10) | Wishart GC, Greenberg DC, Chou P, Duffy S, Brown CH, Purushotham AD. Treatment and survival in breast cancer in the Eastern Region of England. Ann. Oncol. 2010; 21(2): 291-6. | ||||||||||||||||||||
| Specialty Details | |||||||||||||||||||||
| Are all urgent referrals offered same-day imaging and biopsy when required? | Yes | ||||||||||||||||||||
| Number of breast cancers treated annually | 101-200 | ||||||||||||||||||||
| Is specialist breast nurse support available for private patients? | Yes | ||||||||||||||||||||
| Operates on screen-detected cancers | Yes | ||||||||||||||||||||
| Are all private cases discussed at a multidisciplinary meeting following surgery? | Yes | ||||||||||||||||||||
| Is an oncologist always present at this multidisciplinary meeting? | Yes | ||||||||||||||||||||
| Is immediate breast reconstruction offered where appropriate? | Yes | ||||||||||||||||||||
| If yes, is this reconstruction performed with plastic surgeons? | Yes | ||||||||||||||||||||
| Immediate reconstructive procedures that are offered | Implant only Implant & latissimus dorsi (LD) flap Transverse rectus abdominus myocutaneous (TRAM) flap Deep inferior epigastric pedicle (DIEP) flap | ||||||||||||||||||||